DRI Healthcare Trust (TSE:DHT.UN) Shares Up 3.5% – Time to Buy?

DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) shares shot up 3.5% on Tuesday . The stock traded as high as C$18.81 and last traded at C$18.77. 120,525 shares were traded during trading, an increase of 104% from the average session volume of 59,122 shares. The stock had previously closed at C$18.13.

Analysts Set New Price Targets

Several brokerages have weighed in on DHT.UN. Stifel Nicolaus increased their price target on shares of DRI Healthcare Trust from C$22.00 to C$23.00 and gave the company a “buy” rating in a research report on Tuesday, May 19th. National Bank Financial increased their price target on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a research report on Tuesday, May 19th. Finally, Scotiabank increased their price target on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the company a “sector outperform” rating in a research report on Tuesday, May 19th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of C$25.50.

Get DRI Healthcare Trust alerts:

View Our Latest Report on DRI Healthcare Trust

DRI Healthcare Trust Trading Up 1.2%

The firm has a fifty day simple moving average of C$16.81 and a two-hundred day simple moving average of C$16.52. The firm has a market cap of C$1.02 billion, a PE ratio of -20.69 and a beta of 0.47.

DRI Healthcare Trust Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, April 20th. Stockholders of record on Monday, April 20th were given a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Tuesday, March 31st. DRI Healthcare Trust’s dividend payout ratio (DPR) is currently -45.56%.

DRI Healthcare Trust Company Profile

(Get Free Report)

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.

Featured Stories

• Five stocks we like better than DRI Healthcare Trust
• Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
• NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
• The World Cup Is Coming—These 3 Stocks Could Cash In
• Spotify’s “North Star” Outlook Was Music to Investors Ears

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.